Amphastar Pharmaceuticals Inc AMPH

NAS: AMPH | ISIN: US03209R1032 3/07/2025

23,20 USD (-1,61%)

(-1,61%) 3/07/2025

Grafiek Amphastar Pharmaceuticals Inc

Grafiek Amphastar Pharmaceuticals Inc

1 dag1d -1,61%
1 week1w 1,05%
1 maand1m -12,85%
3 maanden3m -7,20%
6 maanden6m -34,18%
1 jaar1j -37,92%
5 jaar5j 7,61%

Amphastar Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

14 juni 2024 · BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC · Persbericht

24 april 2023 · Lilly to Divest BAQSIMI to Amphastar · Persbericht

15 maart 2021 · Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020 · Persbericht

8 maart 2021 · Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021 · Persbericht

26 februari 2021 · Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference · Persbericht

Profiel Amphastar Pharmaceuticals Inc

Fabricage van farmaceutische preparaten

Farmaceutische producten: Andere

Gezondheidstechnologie

Website: www.amphastar.com

Hoofdzetel: Rancho Cucamonga, California Verenigde Staten

CEO: Jack Zhang

Werknemers: 312

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe